131 related articles for article (PubMed ID: 8873158)
1. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group Study.
Deutsch M; Thomas PR; Krischer J; Boyett JM; Albright L; Aronin P; Langston J; Allen JC; Packer RJ; Linggood R; Mulhern R; Stanley P; Stehbens JA; Duffner P; Kun L; Rorke L; Cherlow J; Freidman H; Finlay JL; Vietti T
Pediatr Neurosurg; 1996; 24(4):167-176; discussion 176-7. PubMed ID: 8873158
[TBL] [Abstract][Full Text] [Related]
2. Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.
Thomas PR; Deutsch M; Kepner JL; Boyett JM; Krischer J; Aronin P; Albright L; Allen JC; Packer RJ; Linggood R; Mulhern R; Stehbens JA; Langston J; Stanley P; Duffner P; Rorke L; Cherlow J; Friedman HS; Finlay JL; Vietti TJ; Kun LE
J Clin Oncol; 2000 Aug; 18(16):3004-11. PubMed ID: 10944134
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
[TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated craniospinal radiation in medulloblastoma.
Marymont MH; Geohas J; Tomita T; Strauss L; Brand WN; Mittal BB
Pediatr Neurosurg; 1996; 24(4):178-84. PubMed ID: 8873159
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of conformal radiation therapy for medulloblastoma.
Merchant TE; Happersett L; Finlay JL; Leibel SA
Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience.
Paulino AC; Melian E
Cancer; 1999 Jul; 86(1):142-8. PubMed ID: 10391574
[TBL] [Abstract][Full Text] [Related]
9. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma in childhood: results of radical resection and low-dose neuraxis radiation therapy.
Tomita T; McLone DG
J Neurosurg; 1986 Feb; 64(2):238-42. PubMed ID: 3944633
[TBL] [Abstract][Full Text] [Related]
11. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
[TBL] [Abstract][Full Text] [Related]
13. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F
J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048
[TBL] [Abstract][Full Text] [Related]
14. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
15. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
16. Adult medulloblastoma: multiagent chemotherapy.
Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
[TBL] [Abstract][Full Text] [Related]
17. The impact of myelography on the treatment results for medulloblastoma.
Deutsch M
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):999-1003. PubMed ID: 6746360
[TBL] [Abstract][Full Text] [Related]
18. [Results of radiation therapy for medulloblastoma].
Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in adults: improved survival with supervoltage radiation therapy.
Kopelson G; Linggood RM; Kleinman GM
Cancer; 1982 Apr; 49(7):1334-7. PubMed ID: 6800635
[TBL] [Abstract][Full Text] [Related]
20. The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population.
Yao MS; Mehta MP; Boyett JM; Li H; Donahue B; Rorke LB; Zeltzer PM
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):469-76. PubMed ID: 9231668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
